Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Young women who have a choice of surgical treatment choose mastectomy more often than lumpectomy, or breast-conserving treatment, according to a study presented at a major breast cancer conference.
Researchers found that postmenopausal women who started taking zoledronic acid when they began treatment with the aromatase inhibitor letrozole saw improved bone strength in the spine and hip compared with women who started zoledronic acid after their bone density dropped too low.
European researchers found that radiation therapy given at any dosage for breast cancer increases a woman’s risk of heart disease, with higher doses leading to higher rates of risk.
A study published in the journal Cancer suggests that women with early-stage breast cancer who have a lumpectomy followed by radiation therapy have at least an equal, if not greater, chance of survival compared with those who have a mastectomy without radiation therapy.
Researchers who presented at the American College of Cardiology’s Annual Scientific Session found that race is associated with the risk of developing heart failure after treatment for breast cancer. Heart failure is weakness of the heart muscle that affects the heart’s ability to pump blood throughout the body.
A Washington state study showed higher bankruptcy rates after a cancer diagnosis, especially among young people.
Fear of recurrence, or fear of cancer coming back, is a common psychological effect among people diagnosed with cancer, during or after treatment. A review of several existing studies now shows that fear of recurrence may last more than 5 years beyond the date of diagnosis, and be felt at nearly the same level of intensity as during the first 5 years.
In a landmark decision, the U.S. Supreme Court unanimously ruled that genes taken from the human body could not be patented.
Women diagnosed with early-stage breast cancer that begins in the lobules of the breast gain just as much benefit from treatment with trastuzumab (Herceptin) as women with early-stage cancer that starts in the ducts of the breast, researchers found.
A study suggests age-specific incidences of breast cancer subtypes vary by race, showing that the differences by race occur only when tumor subtypes are grouped together.